The frontier orbital phase angles: Novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens

被引:34
作者
Clare, BW [1 ]
机构
[1] Murdoch Univ, Div Sci, Murdoch, WA 6150, Australia
[2] Univ Western Australia, Dept Chem, Nedlands, WA 6009, Australia
关键词
D O I
10.1021/jm980144c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new empirical electronic descriptor, obtained from a molecular orbital calculation and applicable to benzene derivatives, is proposed. It is shown that this descriptor, the frontier orbital phase angle, correlates very strongly with the pharmacological activity in humans of a large series of hallucinogenic phenethylamines. In the largest QSAR study on such hallucinogens yet reported, it is demonstrated that the phase of mixing of degenerate frontier orbitals of benzene to form the frontier orbitals of the drug results in the best electronic descriptor yet found for hallucinogenic activity in phenylalkylamines.
引用
收藏
页码:3845 / 3856
页数:12
相关论文
共 38 条
[1]   CORRELATION OF PSYCHOTOMIMETIC ACTIVITY OF PHENETHYLAMINES AND AMPHETAMINES WITH 1-OCTANOL-WATER PARTITION-COEFFICIENTS [J].
BARFKNECHT, CF ;
NICHOLS, DE ;
DUNN, WJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (02) :208-210
[2]  
*BMDP, BMDP DYN REL 7
[3]  
BREIMAN L, 1985, J AM STAT ASSOC, V80, P580, DOI 10.2307/2288473
[4]  
CHATTERJEE S, 1977, REGRESSION ANAL EXAM, P199
[5]   STRUCTURE ACTIVITY CORRELATIONS FOR PSYCHOTOMIMETICS .1. PHENYLALKYLAMINES - ELECTRONIC, VOLUME, AND HYDROPHOBICITY PARAMETERS [J].
CLARE, BW .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (02) :687-702
[6]   STRUCTURE ACTIVITY CORRELATIONS FOR PSYCHOTOMIMETICS .2. PHENYLALKYLAMINES - A TREATMENT OF NONLINEARITY USING THE ALTERNATING CONDITIONAL EXPECTATIONS TECHNIQUE [J].
CLARE, BW .
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 1993, 18 (01) :71-92
[7]   FRONTIER ORBITAL ENERGIES IN QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS - A COMPARISON OF QUANTUM-CHEMICAL METHODS [J].
CLARE, BW .
THEORETICA CHIMICA ACTA, 1994, 87 (06) :415-430
[8]  
CLARE BW, UNPUB
[9]  
CLARE BW, 1994, METHODS PRINCIPLES M, V3, P284
[10]  
COHEN S, 1978, PSYCHOPHARMACOLOGY H, P324